Cargando…
HIV protease inhibitors: a review of molecular selectivity and toxicity
Highly active antiretroviral therapy (HAART) is recognized as the most effective treatment method for AIDS, and protease inhibitors play a very important role in HAART. However, poor bioavailability and unbearable toxicity are their common disadvantages. Thus, the development of safer and potentiall...
Autores principales: | Lv, Zhengtong, Chu, Yuan, Wang, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4396582/ https://www.ncbi.nlm.nih.gov/pubmed/25897264 http://dx.doi.org/10.2147/HIV.S79956 |
Ejemplares similares
-
Current and Novel Inhibitors of HIV Protease
por: Pokorná, Jana, et al.
Publicado: (2009) -
Protease-Mediated Maturation of HIV: Inhibitors of Protease and the Maturation Process
por: Adamson, Catherine S.
Publicado: (2012) -
Role of Gag in HIV Resistance to Protease Inhibitors
por: Clavel, François, et al.
Publicado: (2010) -
Protease Inhibitors and Renal Function in Patients with HIV Infection: a Systematic Review
por: Bagnis, Corinne Isnard, et al.
Publicado: (2015) -
Molecular Factors and Pathways of Hepatotoxicity Associated with HIV/SARS-CoV-2 Protease Inhibitors
por: Ji, Cheng
Publicado: (2023)